Boltz vs Grok

Side-by-side comparison of AI visibility scores, market position, and capabilities

Grok leads in AI visibility (49 vs 21)
Boltz logo

Boltz

EmergingHealthcare Tech

AI Biomolecular Prediction

Open-source AI for biomolecular structure prediction. $28M seed from a16z. Pfizer collaboration. Boltz-2 rivals physics methods at 1000x speed. MIT spinout.

AI VisibilityBeta
Overall Score
D21
Category Rank
#1 of 1
AI Consensus
58%
Trend
up
Per Platform
ChatGPT
29
Perplexity
30
Gemini
17

About

Boltz was founded as a spinout from MIT with a mission to democratize access to AI-driven biomolecular structure prediction. The company was inspired by the transformative impact of AlphaFold on structural biology and sought to build the next generation of prediction systems that could go beyond protein structure to model the full complexity of biomolecular interactions, including protein-ligand binding, RNA folding, and multi-chain assemblies. By releasing its models as open source, Boltz made frontier-grade structural biology tools available to any researcher with a computer.\n\nBoltz-2, the company's latest model, rivals physics-based molecular dynamics simulations in accuracy while operating at approximately 1,000 times the speed, compressing computational experiments that once required weeks into hours or minutes. This performance profile makes Boltz-2 practical for drug discovery workflows where structural predictions must be generated across millions of candidate molecules. Boltz entered a collaboration with Pfizer, one of the world's largest pharmaceutical companies, to apply its models to drug discovery programs — a validation of both the technology's accuracy and its readiness for industrial-scale deployment.\n\nBoltz raised a $28 million seed round led by Andreessen Horowitz's bio fund, reflecting a16z's conviction that open-source biomolecular AI represents a foundational layer of the next generation of drug discovery infrastructure. The open-source strategy gives Boltz broad academic adoption and a rich pipeline of community feedback that accelerates model improvement. Its MIT lineage, Pfizer partnership, and a16z backing position Boltz as a leading independent AI platform in the computational biology space.

Full profile
Grok logo

Grok

ChallengerAI & Machine Learning

AI Assistant

AI assistant by xAI (Elon Musk); Grok 3 topped reasoning benchmarks in Feb 2025; 1M+ paying subscribers in week one; real-time X post access; distributed via X Premium; xAI valued at $24B.

AI VisibilityBeta
Overall Score
C49
Category Rank
#4 of 4
AI Consensus
59%
Trend
up
Per Platform
ChatGPT
43
Perplexity
49
Gemini
51

About

Grok is the AI assistant developed by xAI, Elon Musk's AI company founded in 2023, and distributed primarily through X (formerly Twitter). Grok launched in November 2023 as an X Premium perk, with the notable differentiator of real-time access to X posts and a less restricted, more direct conversational style. Grok 3, released in February 2025, achieved top scores on the AIME math reasoning benchmark and ARC-AGI test, briefly positioning xAI as a frontier model lab.

Full profile

AI Visibility Head-to-Head

21
Overall Score
49
#1
Category Rank
#4
58
AI Consensus
59
up
Trend
up
29
ChatGPT
43
30
Perplexity
49
17
Gemini
51
20
Claude
42
15
Grok
59

Key Details

Category
AI Biomolecular Prediction
AI Assistant
Tier
Emerging
Challenger
Entity Type
brand
product

Capabilities & Ecosystem

Capabilities

Only Boltz
AI Biomolecular Prediction
Only Grok
AI Assistant
Grok is classified as product (part of xAI).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.